The current knowledge of the role of PPAR in hepatic ischemia-reperfusion injury

PPAR Research

Volumn , Issue , 2012, Pages

  Elias Miro M ^a   Jimenez Castro M B ^a   Mendes Braz, M ^b   Casillas Ramirez A ^a   Peralta, C ^a,c  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; INTERLEUKIN 1; MITOGEN ACTIVATED PROTEIN KINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; REACTIVE OXYGEN METABOLITE; RETINOID X RECEPTOR; TUMOR NECROSIS FACTOR;

APOPTOSIS; AUTOPHAGY; CYTOKINE RELEASE; ENZYME INHIBITION; FATTY ACID OXIDATION; FATTY LIVER; ISCHEMIC PRECONDITIONING; LEUKOCYTE ACTIVATION; LIVER INJURY; LIVER ISCHEMIA REPERFUSION INJURY; LIVER LEVEL; LIVER REGENERATION; LIVER TRANSPLANTATION; MITOCHONDRIAL RESPIRATION; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PROTEIN BINDING; PROTEIN CONTENT; PROTEIN DNA INTERACTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; REPERFUSION INJURY; REVIEW; TRANSCRIPTION REGULATION; UPREGULATION;

EID: 84862270504     PISSN: 16874757     EISSN: 16874765     Source Type: Journal    
DOI: 10.1155/2012/802384     Document Type: Review

References (105)

1. Massip-salcedo M., Rosell-Catafau J., Prieto J., Avla M. A., Peralta C., The response of the hepatocyte to ischemia Liver International 2007 27 1 6 16 (Pubitemid 46139423)
2. Casillas-Ramrez A., Mosbah I. B., Ramalho F., Rosell-Catafau J., Peralta C., Past and future approaches to ischemia-reperfusion lesion associated with liver transplantation Life Sciences 2006 79 20 1881 1894 (Pubitemid 44488610)
3. Selzner M., Clavien P. A., Fatty liver in liver transplantation and surgery Seminars in Liver Disease 2001 21 1 105 113 (Pubitemid 32240490)
4. Peralta C., Rosell-Catafau J., The future of fatty livers Journal of Hepatology 2004 41 1 149 151 (Pubitemid 39005167)
5. Busuttil R. W., Tanaka K., The utility of marginal donors in liver transplantation Liver Transplantation 2003 9 7 651 663 (Pubitemid 36874450)
6. Kuboki S., Shin T., Huber N., Eismann T., Galloway E., Schuster R., Blanchard J., Zingarelli B., Lentsch A. B., Peroxisome proliferator-activated receptor- protects against hepatic ischemia/reperfusion injury in mice Hepatology 2008 47 1 215 224 (Pubitemid 351171059)
7. Akahori T., Sho M., Hamada K., Suzaki Y., Kuzumoto Y., Nomi T., Nakamura S., Enomoto K., Kanehiro H., Nakajima Y., Importance of peroxisome proliferator-activated receptor- in hepatic ischemia/reperfusion injury in mice Journal of Hepatology 2007 47 6 784 792 (Pubitemid 350051123)
8. Tailleux A., Wouters K., Staels B., Roles of PPARs in NAFLD: potential therapeutic targets Biochimia et Biophysica Acta 2012 1821 5 809 818
9. Boelsterli U. A., Bedoucha M., Toxicological consequences of altered peroxisome proliferator-activated receptor (PPAR ) expression in the liver: Insights from models of obesity and type 2 diabetes Biochemical Pharmacology 2002 63 1 1 10 (Pubitemid 34075287)
10. Lumeng C. N., Saltiel A. R., Inflammatory links between obesity and metabolic disease Journal of Clinical Investigation 2011 121 6 2111 2117
11. Yessoufou A., Wahli W., Multifaceted roles of peroxisome proliferator-activated receptors (PPARs) at the cellular and whole organism levels Swiss Medical Weekly 2010 140 w13071 w13080
12. Straus D. S., Glass C. K., Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms Trends in Immunology 2007 28 12 551 558 (Pubitemid 350101420)
13. Massip-Salcedo M., Zaouali M. A., Padrissa-Altés S., Casillas-Ramrez A., Rodés J., Rosell-Catafau J., Peralta C., Activation of peroxisome proliferator-activated receptor- inhibits the injurious effects of adiponectin in rat steatotic liver undergoing ischemia-reperfusion Hepatology 2008 47 2 461 472 (Pubitemid 351280714)
14. Casillas-Ramrez A., Alfany-Fernndez I., Massip-Salcedo M., Juan M. E., Planas J. M., Serafn A., Palls M., Rimola A., Rodés J., Peralta C., Retinol-binding protein 4 and peroxisome proliferator-activated receptor- in steatotic liver transplantation Journal of Pharmacology and Experimental Therapeutics 2011 338 1 143 153
15. Zhao C. Y., Jiang L. L., Li L., Deng Z. J., Liang B. L., Li J. M., Peroxisome proliferator activated receptor- in pathogenesis of experimental fatty liver disease World Journal of Gastroenterology 2004 10 9 1329 1332 (Pubitemid 39162441)
16. Inoue M., Ohtake T., Motomura W., Takahashi N., Hosoki Y., Miyoshi S., Suzuki Y., Saito H., Kohgo Y., Okumura T., Increased expression of PPAR in high fat diet-induced liver steatosis in mice Biochemical and Biophysical Research Communications 2005 336 1 215 222 (Pubitemid 41253423)
17. Lanne B., Dahllf B., Lindahl C., Ebefors K., Kanmert I., von Bahr H., Miliotis T., Nystrm A. C., Arnerup G., Paulsons I., Kerb S., Oakes N., PPAR and PPAR regulation of liver and adipose proteins in obese and dyslipidemic rodents Journal of Proteome Research 2006 5 8 1850 1859 (Pubitemid 44232698)
18. Duval C., Thissen U., Keshtkar S., Accart B., Stienstra R., Boekschoten M. V., Roskams T., Kersten S., Mller M., Adipose tissue dysfunction signals progression of hepatic steatosis towards nonalcoholic steatohepatitis in C57Bl/6 mice Diabetes 2010 59 12 3181 3191
19. Pettinelli P., Videla L. A., Up-regulation of PPAR- mRNA expression in the liver of obese patients: an additional reinforcing lipogenic mechanism to SREBP-1c induction Journal of Clinical Endocrinology and Metabolism 2011 96 5 1424 1430
20. Pettinelli P., del Pozo T., Araya J., Rodrigo R., Araya A. V., Smok G., Csendes A., Gutierrez L., Rojas J., Korn O., Maluenda F., Diaz J. C., Rencoret G., Braghetto I., Castillo J., Poniachik J., Videla L. A., Enhancement in liver SREBP-1c/PPAR- ratio and steatosis in obese patients: correlations with insulin resistance and n-3 long-chain polyunsaturated fatty acid depletion Biochimica et Biophysica Acta 2009 1792 11 1080 1086
21. Ricote M., Glass C. K., PPARs and molecular mechanisms of transrepression Biochimica et Biophysica Acta 2007 1771 8 926 935 (Pubitemid 47198544)
22. Willson T. M., Lambert M. H., Kliewer S. A., Peroxisome proliferator-activated receptor and metabolic disease Annual Review of Biochemistry 2001 70 341 367 (Pubitemid 32662214)
23. Okaya T., Lentsch A. B., Peroxisome proliferator-activated receptor- regulates postischemic liver injury American Journal of Physiology 2004 286 4 G606 G612
24. Xu S. Q., Li Y. H., Hu S. H., Chen K., Dong L. Y., Effects of Wy14643 on hepatic ischemia reperfusion injury in rats World Journal of Gastroenterology 2008 14 45 6936 6942
25. Teoh N. C., Williams J., Hartley J., Yu J., McCuskey R. S., Farrell G. C., Short-term therapy with peroxisome proliferation-activator receptor-alpha agonist Wy-14,643 protects murine fatty liver against ischemia-reperfusion injury Hepatology 2010 51 3 996 1006
26. Gao W., Connor H. D., Lemasters J. J., Mason R. P., Thurman R. G., Primary nonfunction of fatty livers produced by alcohol is associated with a new, antioxidant-insensitive free radical species Transplantation 1995 59 5 674 679
27. Wheeler M. D., Katuna M., Smutney O. M., Froh M., Dikalova A., Mason R. P., Samulski R. J., Thurman R. G., Comparison of the effect of adenoviral delivery of three superoxide dismutase genes against hepatic ischemia-reperfusion injury Human Gene Therapy 2001 12 18 2167 2177 (Pubitemid 34081176)
28. Ziga J., Cancino M., Medina F., N-3 PUFA supplementation triggers PPAR- activation and PPAR- /NF- B interaction: anti-inflammatory implications in liver ischemia-reperfusion injury PLoS One 2011 16 12
29. Jiang C., Ting A. T., Seed B., PPAR- agonists inhibit production of monocyte inflammatory cytokines Nature 1998 391 6662 82 86 (Pubitemid 28079219)
30. von Knethen A., Brune B., PPAR : an important regulator of monocyte/macrophage function Archivum Immunologiae et Therapiae Experimentalis 2003 51 4 219 226 (Pubitemid 37040061)
31. Ramalho F. S., Alfany-Fernandez I., Casillas-Ramrez A., Massip-Salcedo M., Serafn A., Rimola A., Arroyo V., Rodés J., Rosell-Catafau J., Peralta C., Are angiotensin II receptor antagonists useful strategies in steatotic and nonsteatotic livers in conditions of partial hepatectomy under ischemia-reperfusion? Journal of Pharmacology and Experimental Therapeutics 2009 329 1 130 140
32. Saidi R. F., Chang J., Verb S., The effect of methylprednisolone on warm ischemia-reperfusion injury in the liver American Journal of Surgery 2007 193 3 345 347
33. Yorimitsu T., Klionsky D. J., Autophagy: molecular machinery for self-eating Cell Death and Differentiation 2005 12 2 1542 1552 (Pubitemid 41553991)
34. Zaouali M. A., Padrissa-Altés S., Mosbah I. B., Alfany-Fernandez I., Massip-Salcedo M., Casillas-Ramrez A., Bintanel-Morcillo M., Boillot O., Serafin A., Rimola A., Rodés J., Rosell-Catafau J., Peralta C., Improved rat steatotic and nonsteatotic liver preservation by the addition of epidermal growth factor and insulin-like growth factor-I to University of Wisconsin solution Liver Transplantation 2010 16 9 1098 1111
35. Casillas-Ramrez A., Zaouali A., Padrissa-Altés S., Mosbah I. B., Pertosa A., Alfany-Fernndez I., Bintanel-Morcillo M., Xaus C., Rimola A., Rodés J., Rosell-Catafau J., Peralta C., Insulin-like growth factor and epidermal growth factor treatment: New approaches to protecting steatotic livers against ischemia-reperfusion injury Endocrinology 2009 150 7 3153 3161
36. Casillas-Ramrez A., Amine-Zaouali M., Massip-Salcedo M., Padrissa-Altés S., Bintanel-Morcillo M., Ramalho F., Serafn A., Rimola A., Arroyo V., Rodés J., Rosell-Catafau J., Peralta C., Inhibition of angiotensin II action protects rat steatotic livers against ischemia-reperfusion injury Critical Care Medicine 2008 36 4 1256 1266 (Pubitemid 351482676)
37. Ip E., Farrell G. C., Robertson G., Hall P., Kirsch R., Leclercq I., Central role of PPAR -dependent hepatic lipid turnover in dietary steatohepatitis in mice Hepatology 2003 38 1 123 132 (Pubitemid 36775803)
38. Ip E., Farrell G., Hall P., Robertson G., Leclercq I., Administration of the potent PPAR agonist, Wy-14,643, reverses nutritional fibrosis and steatohepatitis in mice Hepatology 2004 39 5 1286 1296 (Pubitemid 38569050)
39. Nagasawa T., Inada Y., Nakano S., Tamura T., Takahashi T., Maruyama K., Yamazaki Y., Kuroda J., Shibata N., Effects of bezafibrate, PPAR pan-agonist, and GW501516, PPAR agonist, on development of steatohepatitis in mice fed a methionine- and choline-deficient diet European Journal of Pharmacology 2006 536 1-2 182 191
40. Zabielski P., Blachnio-Zabielska A., Baranowski M., Zendzian-Piotrowska M., Gorski J., Activation of PPAR by bezafibrate negatively affects de novo synthesis of sphingolipids in regenerating rat liver Prostaglandins and Other Lipid Mediators 2010 93 3-4 120 125
41. Tanaka N., Sano K., Horiuchi A., Tanaka E., Kiyosawa K., Aoyama T., Highly purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis Journal of Clinical Gastroenterology 2008 42 4 413 418 (Pubitemid 351450629)
42. Capanni M., Calella F., Biagini M. R., Genise S., Raimondi L., Bedogni G., Svegliati-Baroni G., Sofi F., Milani S., Abbate R., Surrenti C., Casini A., Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: a pilot study Alimentary Pharmacology and Therapeutics 2006 23 8 1143 1151 (Pubitemid 43779354)
43. Spadaro L., Magliocco O., Spampinato D., Piro S., Oliveri C., Alagona C., Papa G., Rabuazzo A. M., Purrello F., Effects of n-3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease Digestive and Liver Disease 2008 40 3 194 199 (Pubitemid 351181793)
44. Zhu F. S., Liu S., Chen X. M., Huang Z. G., Zhang D. W., Effects of n-3 polyunsaturated fatty acids from seal oils on nonalcoholic fatty liver disease associated with hyperlipidemia World Journal of Gastroenterology 2008 14 41 6395 6400
45. Hatzitolios A., Savopoulos C., Lazaraki G., Sidiropoulos I., Haritanti P., Lefkopoulos A., Karagiannopoulou G., Tzioufa V., Dimitrios K., Efficacy of omega-3 fatty acids, atorvastatin and orlistat in non-alcoholic fatty liver disease with dyslipidemia Indian Journal of Gastroenterology 2004 23 4 131 134 (Pubitemid 39145721)
46. Kersten S., Seydoux J., Peters J. M., Gonzalez F. J., Desvergne B., Wahli W., Peroxisome proliferator-activated receptor mediates the adaptive response to fasting Journal of Clinical Investigation 1999 103 11 1489 1498
47. Anderson S. P., Yoon L., Richard E. B., Dunn C. S., Cattley R. C., Corton J. C., Delayed liver regeneration in peroxisome proliferator-activated receptor- -null mice Hepatology 2002 36 3 544 554 (Pubitemid 34977164)
48. Gavrilova O., Haluzik M., Matsusue K., Cutson J. J., Johnson L., Dietz K. R., Nicol C. J., Vinson C., Gonzalez F. J., Reitman M. L., Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass The Journal of Biological Chemistry 2003 278 36 34268 34276 (Pubitemid 37553270)
49. Garca-Ruiz I., Rodrguez-Juan C., Daz-Sanjun T., Martnez M., Muoz-Yage T., Sols-Herruzo J. A., Effects of rosiglitazone on the liver histology and mitochondrial function in ob/ob mice Hepatology 2007 46 2 414 423
50. Turmelle Y. P., Shikapwashya O., Tu S., Hruz P. W., Yan Q., Rudnick D. A., Rosiglitazone inhibits mouse liver regeneration The FASEB Journal 2006 20 14 2609 2611
51. Yu S., Matsusue K., Kashireddy P., Adipocyte-specific gene expression and adipogenicsteatosis in the mouse liver due to peroxisome proliferator-activated receptor 1 (PPAR 1) overexpression The Journal of Biological Chemistry 2003 278 1 498 505 (Pubitemid 36043602)
52. Enomoto N., Takei Y., Hirose M., Konno A., Shibuya T., Matsuyama S., Suzuki S., Kitamura K. I. T., Sato N., Prevention of ethanol-induced liver injury in rats by an agonist of peroxisome proliferator-activated receptor-, pioglitazone Journal of Pharmacology and Experimental Therapeutics 2003 306 3 846 854 (Pubitemid 37025289)
53. Sanyal A. J., Chalasani N., Kowdley K. V., McCullough A., Diehl A. M., Bass N. M., Neuschwander-Tetri B. A., Lavine J. E., Tonascia J., Unalp A., Van Natta M., Clark J., Brunt E. M., Kleiner D. E., Hoofnagle J. H., Robuck P. R., Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis The New England Journal of Medicine 2010 362 18 1675 1685
54. Aoyama T., Ikejima K., Kon K., Okumura K., Arai K., Watanabe S., Pioglitazone promotes survival and prevents hepatic regeneration failure after partial hepatectomy in obese and diabetic KK-Ay mice Hepatology 2009 49 5 1636 1644
55. Nan Y. M., Han F., Kong L. B., Zhao S. X., Wang R. Q., Wu W. J., Yu J., Adenovirus-mediated peroxisome proliferator activated receptor gamma overexpression prevents nutritional fibrotic steatohepatitis in mice Scandinavian Journal of Gastroenterology 2011 46 3 358 369
56. Matsusue K., Haluzik M., Lambert G., Yim S. H., Gavrilova O., Ward J. M., Brewer B., Reitman M. L., Gonzalez F. J., Liver-specific disruption of PPAR in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes Journal of Clinical Investigation 2003 111 5 737 747 (Pubitemid 36278592)
57. Lee S. S. T., Pineau T., Drago J., Lee E. J., Owens J. W., Kroetz D. L., Fernandez- Salguero P. M., Westphal H., Gonzalez F. J., Targeted disruption of the isoform of the peroxisome proliferator- activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators Molecular and Cellular Biology 1995 15 6 3012 3022
58. Reddy J. K., Nonalcoholic steatosis and steatohepatitis III. Peroxisomal -oxidation, PPAR, and steatohepatitis American Journal of Physiology 2001 281 6 G1333 G1339
59. Clarke S. D., Polyunsaturated fatty acid regulation of gene transcription: a molecular mechanism to improve the metabolic syndrome Journal of Nutrition 2001 131 4 1129 1132 (Pubitemid 32275088)
60. Delarue J., LeFoll C., Corporeau C., Lucas D., N-3 long chain polyunsaturated fatty acids: a nutritional tool to prevent insulin resistance associated to type 2 diabetes and obesity? Reproduction Nutrition Development 2004 44 3 289 299 (Pubitemid 39198971)
61. Lombardo Y. B., Chicco A. G., Effects of dietary polyunsaturated n-3 fatty acids on dyslipidemia and insulin resistance in rodents and humans. A review Journal of Nutritional Biochemistry 2006 17 1 1 13 (Pubitemid 41774400)
62. Neschen S., Moore I., Regittnig W., Yu C. L., Wang Y., Pypaert M., Petersen K. F., Shulman G. I., Contrasting effects of fish oil and safflower oil on hepatic peroxisomal and tissue lipid content American Journal of Physiology 2002 282 2 E395 E401
63. Shteyer E., Liao Y., Muglia L. J., Hruz P. W., Rudnick D. A., Disruption of hepatic adipogenesis is associated with impaired liver regeneration in mice Hepatology 2004 40 6 1322 1332 (Pubitemid 39657006)
64. Ezaki H., Yoshida Y., Saji Y., Takemura T., Fukushima J., Matsumoto H., Kamada Y., Wada A., Igura T., Kihara S., Funahashi T., Shimomura I., Tamura S., Kiso S., Hayashi N., Delayed liver regeneration after partial hepatectomy in adiponectin knockout mice Biochemical and Biophysical Research Communications 2009 378 1 68 72
65. Fernndez M. A., Albor C., Ingelmo-Torres M., Nixon S. J., Ferguson C., Kurzchalia T., Tebar F., Enrich C., Parton R. G., Pol A., Caveolin-1 is essential for liver regeneration Science 2006 313 5793 1628 1632 (Pubitemid 44414035)
66. Walldorf J., Hillebrand C., Aurich H., Stock P., Hempel M., Ebensing S., Fleig W. E., Seufferlein T., Dollinger M. M., Christ B., Propranolol impairs liver regeneration after partial hepatectomy in C57Bl/6-mice by transient attenuation of hepatic lipid accumulation and increased apoptosis Scandinavian Journal of Gastroenterology 2010 45 4 468 476
67. Moran-Salvador E., Lopez-Parra M., Garcia-Alonso V., Role for PPAR in obesity-induced hepatic steatosis as determined by hepatocyte- and macrophage-specific conditional knockouts The FASEB Journal 2011 25 8 2538 2550
68. Selzner M., Clavien P. A., Failure of regeneration of the steatotic rat liver: disruption at two different levels in the regeneration pathway Hepatology 2000 31 1 35 42 (Pubitemid 30033686)
69. Yang S. Q., Mandal A. K., Huang J., Diehl A. M., Disrupted signaling and inhibited regeneration in obese mice with fatty livers: implications for nonalcoholic fatty liver disease pathophysiology Hepatology 2001 34 4 I 694 706 (Pubitemid 32927993)
70. Leclercq I. A., Field J., Farrell G. C., Leptin-specific mechanisms for impaired liver regeneration in ob/ob mice after toxic injury Gastroenterology 2003 124 5 1451 1464 (Pubitemid 36531818)
71. Yamauchi H., Uetsuka K., Okada T., Nakayama H., Doi K., Impaired liver regeneration after partial hepatectomy in db/db mice Experimental and Toxicologic Pathology 2003 54 4 281 286 (Pubitemid 36362232)
72. DeAngelis R. A., Markiewski M. M., Taub R., Lambris J. D., A high-fat diet impairs liver regeneration in C57BL/6 mice through overexpression of the NF- B inhibitor, I B Hepatology 2005 42 5 1148 1157 (Pubitemid 43112682)
73. Rudnick D. A., Trimming the fat from liver regeneration Hepatology 2005 42 5 1001 1003 (Pubitemid 43112664)
74. Lai H. S., Chen W. J., Alterations of remnant liver carnitine palmitoyltransferase I activity and serum carnitine concentration after partial hepatectomy in rats Journal of Surgical Research 1995 59 6 754 758
75. Aoyama T., Peters J. M., Iritani N., Nakajima T., Furihata K., Hashimoto T., Gonzalez F. J., Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor (PPAR ) The Journal of Biological Chemistry 1998 273 10 5678 5684 (Pubitemid 28124039)
76. Farrell G. C., Probing Prometheus: fat fueling the fire? Hepatology 2004 40 6 1252 1255 (Pubitemid 39656997)
77. Chinetti G., Fruchart J. C., Staels B., Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation Inflammation Research 2000 49 10 497 505
78. Tsai C. Y., Lin Y. S., Yeh T. S., Cheong C. F., Chang C. H., Chen T. C., Chen M. F., Disrupted hepatic adiponectin signaling impairs liver regeneration of steatotic rats Chang Gung Medical Journal 2011 34 3 248 259
79. Schoonjans K., Auwerx J., Thiazolidinediones: an update The Lancet 2000 355 9208 1008 1010 (Pubitemid 30148273)
80. Yki-Jarvinen H., Thiazolidinediones The New England Journal of Medicine 2004 351 11 1106 1118
81. Plutzky J., The potential role of peroxisome proliferator-activated receptors on inflammation in type 2 diabetes mellitus and atherosclerosis. The American Journal of Cardiology 2003 92 4 34J 41J
82. Kohlroser J., Mathai J., Reichheld J., Banner B. F., Bonkovsky H. L., Hepatotoxicity due to troglitazone: report of two cases and review of adverse events reported to the United States food and drug administration American Journal of Gastroenterology 2000 95 1 272 276 (Pubitemid 30041572)
83. Tolman K. G., Thiazolidinedione hepatotoxicity: a class effect? International Journal of Clinical Practice 2000 113 29 34
84. Marcy T. R., Britton M. L., Blevins S. M., Second-generation thiazolidinediones and hepatotoxicity Annals of Pharmacotherapy 2004 38 9 1419 1423 (Pubitemid 39100194)
85. Bulhak A. A., Jung C., Ostenson C. G., Lundberg J. O., Sjquist P. O., Pernow J., PPAR- activation protects the type 2 diabetic myocardium against ischemia-reperfusion injury: involvement of the PI3-kinase/Akt and NO pathway American Journal of Physiology 2009 296 3 H719 H727
86. Woods C. G., Burns A. M., Bradford B. U., Ross P. K., Kosyk O., Swenberg J. A., Cunningham M. L., Rusyn I., WY-14,643-induced cell proliferation and oxidative stress in mouse liver are independent of NADPH oxidase Toxicological Sciences 2007 98 2 366 374 (Pubitemid 47244809)
87. Lovett-Racke A. E., Hussain R. Z., Northrop S., Choy J., Rocchini A., Matthes L., Chavis J. A., Diab A., Drew P. D., Racke M. K., Peroxisome proliferator-activated receptor agonists as therapy for autoimmune disease Journal of Immunology 2004 172 9 5790 5798 (Pubitemid 38542085)
88. Rusyn I., Asakura S., Pachkowski B., Bradford B. U., Denissenko M. F., Peters J. M., Holland S. M., Reddy J. K., Cunningham M. L., Swenberg J. A., Expression of base excisionDNArepair genes is a sensitive biomarker for in vivo detection of chemical-induced chronic oxidative stress: identification of the molecular marker source of radicals responsible for DNA damage by peroxisome proliferators Cancer Research 2004 64 3 1050 1057 (Pubitemid 38176909)
89. Li Y., Leung L. K., Glauert H. P., Spear B. T., Treatment of rats with the peroxisome proliferator ciprofibrate results in increased liver NF- B activity Carcinogenesis 1996 17 11 2305 2309 (Pubitemid 26402226)
90. Rusyn I., Yamashina S., Segal B. H., Schoonhoven R., Holland S. M., Cattley R. C., Swenberg J. A., Thurman R. G., Oxidants from nicotinamide adenine dinucleotide phosphate oxidase are involved in triggering cell proliferation in the liver due to peroxisome proliferators Cancer Research 2000 60 17 4798 4803
91. Serafn A., Rosell-Catafau J., Prats N., Gelp E., Rodés J., Peralta C., Ischemic preconditioning affects interleukin release in fatty livers of rats undergoing ischemia/reperfusion Hepatology 2004 39 3 688 698 (Pubitemid 38337648)
92. Elias-Mir M., Massip-Salcedo M., Jimenez-Castro M., Peralta C., Does adiponectin benefit steatotic liver transplantation? Liver Transplantation 2011 17 9 993 1004
93. Jimenez-Castro M. B., Casillas-Ramrez A., Massip-Salcedo M., Cyclic adenosine 3′,5′-monophosphate in rat steatotic liver transplantation Liver Transplantation 2011 17 9 1099 1110
94. Clavien P. A., Selzner M., Rudiger H. A., Graf R., Kadry Z., Rousson V., Jochum W., A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning Annals of Surgery 2003 238 6 843 852 (Pubitemid 38174467)
95. Choukr A., Martignoni A., Schauer R., Dugas M., Rau H. G., Jauch K. W., Peter K., Thiel M., Beneficial effects of ischemic preconditioning in patients undergoing hepatectomy: the role of neutrophils Archives of Surgery 2005 140 2 129 136 (Pubitemid 40229099)
96. Nuzzo G., Giuliante F., Vellone M., de Cosmo G., Ardito F., Murazio M., D'Acapito F., Giovannini I., Pedicle clamping with ischemic preconditioning in liver resection Liver Transplantation 2004 10 2 supplement 1 S53 S57
97. Azoulay D., Lucidi V., Andreani P., Maggi U., Sebagh M., Ichai P., Lemoine A., Adam R., Castaing D., Ischemic preconditioning for major liver resection under vascular exclusion of the liver preserving the caval flow: a randomized prospective study Journal of the American College of Surgeons 2006 202 2 203 211 (Pubitemid 43112477)
98. Rahbari N. N., Wente M. N., Schemmer P., Diener M. K., Hoffmann K., Motschall E., Schmidt J., Weitz J., Bchler M. W., Systematic review and meta-analysis of the effect of portal triad clamping on outcome after hepatic resection British Journal of Surgery 2008 95 4 424 432
99. Azoulay D., Del Gaudio M., Andreani P., Ichai P., Sebag M., Adam R., Scatton O., Min B. Y., Delvard V., Lemoine A., Bismuth H., Castaing D., Effects of 10 minutes of ischemic preconditioning of the cadaveric liver on the graft's preservation and function Annals of Surgery 2005 242 1 133 139 (Pubitemid 40917977)
100. Cescon M., Grazi G. L., Grassi A., Ravaioli M., Vetrone G., Ercolani G., Varotti G., D'Errico A., Ballardini G., Pinna A. D., Effect of ischemic preconditioning in whole liver transplantation from deceased donors. A pilot study Liver Transplantation 2006 12 4 628 635
101. Amador A., Grande L., Mart J., Deulofeu R., Miquel R., Sol A., Rodriguez-Laiz G., Ferrer J., Fondevila C., Charco R., Fuster J., Hotter G., Garca-Valdecasas J. C., Ischemic pre-conditioning in deceased donor liver transplantation: a prospective randomized clinical trial American Journal of Transplantation 2007 7 9 2180 2189 (Pubitemid 47247061)
102. Koneru B., Shareef A., Dikdan G., Desai K., Klein K. M., Peng B., Wachsberg R. H., de la Torre A. N., Debroy M., Fisher A., Wilson D. J., Samanta A. K., The ischemic preconditioning paradox in deceased donor liver transplantationevidence from a prospective randomized single blind clinical trial American Journal of Transplantation 2007 7 12 2788 2796 (Pubitemid 350045783)
103. Clavien P. A., Yadav S., Sindram D., Bentley R. C., Protective effects of ischemic preconditioning for liver resection performed under inflow occlusion in humans Annals of Surgery 2000 232 2 155 162 (Pubitemid 30616712)
104. Li S. Q., Liang L. J., Huang J. F., Li Z., Ischemic preconditioning protects liver from hepatectomy under hepatic inflow occlusion for hepatocellular carcinoma patients with cirrhosis World Journal of Gastroenterology 2004 10 17 2580 2584 (Pubitemid 39206785)
105. Yamagami K., Hutter J., Yamamoto Y., Schauer R. J., Enders G., Leiderer R., zen O., Hammer C., Yamaoka Y., Messmer K., Synergistic effects of brain death and liver steatosis on the hepatic microcirculation Transplantation 2005 80 4 500 505 (Pubitemid 41209419)